当前位置:Public Access >页面
Chinese/English
A Phase I/II Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profile and Antitumor Activity of FCN-338 in Patients with Relapsed or Refractory B-Cell Lymphoma
Filter Options
Patient No. Patient Name Patient Gender
Sitting Education Date of enrollment FromTo
       More Options
Patient No Gender Date of enrollment Sitting Creater Operate
NO participants recorded。